Clinical trials submitted to the JID: Place your bet and show us your hand

Journal of Investigative Dermatology

Volumn 135, Issue 2, 2015, Pages 325-327

  Williams, Hywel C ^a   Gilchrest, Barbara A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATOPIC DERMATITIS; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL INFORMATION; MEDICAL LITERATURE; META ANALYSIS (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); DERMATOLOGY; PUBLICATION;

DERMATOLOGY; HUMANS; PERIODICALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84925359642     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.478     Document Type: Editorial

References (19)

1. Beissert S, Mimouni D, Kanwar AJ et al. (2010) Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial. J Invest Dermatol 130:2041-8
2. Chalmers I, Glasziou P (2009) Avoidable waste in the production and reporting of research evidence. Lancet 374:86-9
3. Chan AW, Altman DG (2005) Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ 330:753
4. Crofton J (2006) The MRC randomized trial of streptomycin and its legacy: a view from the clinical front line. J R Soc Med 99:531-4
5. Do-Pham G, Le Cleach L, Giraudeau B et al. (2014) Designing randomized-controlled trials to improve head-louse treatment: systematic review using a vignette-based method. J Invest Dermatol 134:628-34
6. Goldacre B (2012) Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients. London: Fourth Estate, 171-223
7. Higgins JPT, Green S (eds) (2011) Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. The Cochrane Collaboration. http://www.cochrane-handbook.org
8. Joly P, Roujeau JC, Benichou J et al. (2009) A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol 129:1681-7
9. Kunz CU, Friede T, Parsons N et al. (2014) A comparison of methods for treatment selection in seamless phase II/III clinical trials incorporating information on short-term endpoints. J Biopharm Stat, e-pub ahead of print 3 April 2014
10. Nankervis H, Baibergenova A, Williams HC et al. (2012) Prospective registration and outcome-reporting bias in randomized controlled trials of eczema treatments: a systematic review. J Invest Dermatol 132:2727-34
11. Papp KA, Reid C, Foley P et al. (2012) Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial. J Invest Dermatol 132:2466-9
12. Parmar MK, Carpenter J, Sydes MR (2014) More multiarm randomised trials of superiority are needed. Lancet 384:283-4
13. Williams HC (2010) Cars, CONSORT 2010 and clinical practice. Trials 11:33
14. Williams HC (2011) Evidence-based dermatology - everyone's business. Am J Clin Dermatol 12:357-9
15. Williams H (2014) The outstanding record of clinical trials in the British Journal of Dermatology. Br J Dermatol 170:761-3
16. Williams HC, Bergstresser P (2010) The case for structured abstracts. J Invest Dermatol 130:2691-2
17. Williams HC, Dellavalle RP (2012) The growth of clinical trials and systematic reviews in informing dermatological patient care. J Invest Dermatol 132:1008-17
18. Williams HC, Goldsmith L (2006) The JID opens its doors to high-quality randomized controlled clinical trials. J Invest Dermatol 126:1683-4
19. Williams HC, Stern RS (2005) Prospective trials registration. J Invest Dermatol 124:vii